Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated statements of comprehensive income (loss)

v3.23.1
Consolidated statements of comprehensive income (loss) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]      
Revenue $ 193,234 $ 137,668 $ 93,486
Cost of revenue 53,274 31,752 21,417
Gross profit 139,960 105,916 72,069
Operating expenses      
Research and development 59,904 44,378 22,086
Sales and marketing 122,635 93,844 53,690
General and administrative 45,277 33,801 15,967
Total operating expenses 227,816 172,023 91,743
Loss from operations (87,856) (66,107) (19,674)
Other income, net 290 0 0
Finance (expenses) income, net 4,421 (1,891) (1,682)
Loss before income taxes (83,145) (67,998) (21,356)
Provision for income taxes 516 981 640
Net loss (83,661) (68,979) (21,996)
Supplemental Income Statement Elements [Abstract]      
Deemed dividend to ordinary and preferred shareholders $ 0 $ 0 $ (825)
Net loss per share attributable to ordinary shareholders, basic (in USD per share) $ (1.10) $ (1.30) $ (1.58)
Net loss per share attributable to ordinary shareholders, diluted (in USD per share) $ (1.10) $ (1.30) $ (1.58)
Weighted-average shares used in computing net loss per share attributable to ordinary shareholders, basic (in shares) 75,718,623 53,201,603 14,442,172
Weighted-average shares used in computing net loss per share attributable to ordinary shareholders, diluted (in shares) 75,718,623 53,201,603 14,442,172
Other comprehensive (loss) income, net of tax      
Change in unrealized (loss) gain on cashflow hedges $ (527) $ 84 $ (73)
Total other comprehensive (loss) income, net of tax (527) 84 (73)
Total comprehensive loss $ (84,188) $ (68,895) $ (22,069)